9 METERS BIOPHARMA, INC.【NMTRQ】
| Dec 31,
2016 | Dec 31,
2017 | Dec 31,
2018 | Dec 31,
2019 | Dec 31,
2020 | Dec 31,
2021 | Dec 31,
2022 |
|---|
| Cash and cash equivalents | - | - | 6 | - | - | 47 | 13 |
|---|
| Prepaid expenses and other current assets | 1 | 0 | 504,907 | 555,052 | 1 | 3 | 3 |
|---|
| Restricted cash | - | - | - | - | - | - | 17 |
|---|
| Total current assets | 4 | 1 | 6 | 5 | 39 | 50 | 33 |
|---|
| Property and equipment, net | - | - | 35,095 | 25,422 | 11,191 | 16,094 | 10,413 |
|---|
| Right-of-use asset | - | - | - | 42,830 | 214,767 | 166,618 | 112,302 |
|---|
| Other assets | - | - | 5,580 | 5,580 | 5,580 | 5,580 | 7,280 |
|---|
| Total assets | 6 | 1 | 6 | 5 | 39 | 50 | 33 |
|---|
| Accounts payable | 0 | 0 | 4 | 4 | 1 | 2 | 5 |
|---|
| Accrued expenses | 2 | 1 | 826,327 | 5 | 5 | 6 | 4 |
|---|
| Convertible note payable, net | - | - | - | 3 | 14,216 | - | 20 |
|---|
| Derivative liability | - | - | 370,000 | 408,000 | 7,000 | - | 2 |
|---|
| Lease liability, current portion | - | - | - | 42,830 | 48,629 | 54,796 | 61,746 |
|---|
| Total current liabilities | 4 | 3 | 10 | 15 | 7 | 8 | 31 |
|---|
| Operating Lease, Liability, Noncurrent | - | - | - | - | 167,938 | 113,142 | 51,396 |
|---|
| Total liabilities | - | - | - | - | 7 | 9 | 31 |
|---|
| Preferred Stock, Value, Issued | - | - | - | - | - | - | - |
|---|
| Common Stock, Value, Issued | 0 | 0 | 2,609 | 3,948 | 20,463 | 25,824 | 1,304 |
|---|
| Additional paid-in capital | 35 | 38 | 40 | 61 | 164 | 210 | 215 |
|---|
| Accumulated deficit | -32 | -40 | -43,515,970 | -70,564,778 | -132,061,267 | -168,840,667 | -212,607,082 |
|---|
| Total stockholders’ equity | 2 | -2 | -3,659,064 | -9,614,014 | 32 | 42 | 2 |
|---|
| Total liabilities and stockholders’ equity | 6 | 1 | 6 | 5 | 39 | 50 | 33 |
|---|